These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35908936)

  • 1. Response to the Letter to the Editor Regarding "Serologic Survey of IgG Against SARS-CoV-2 Among Hospital Visitors Without a History of SARS-CoV-2 Infection in Tokyo, 2020-2021".
    Sanada T; Kohara M
    J Epidemiol; 2023 Feb; 33(2):109. PubMed ID: 35908936
    [No Abstract]   [Full Text] [Related]  

  • 2. Serologic Survey of IgG Against SARS-CoV-2 Among Hospital Visitors Without a History of SARS-CoV-2 Infection in Tokyo, 2020-2021.
    Sanada T; Honda T; Yasui F; Yamaji K; Munakata T; Yamamoto N; Kurano M; Matsumoto Y; Kohno R; Toyama S; Kishi Y; Horibe T; Kaneko Y; Kakegawa M; Fukui K; Kawamura T; Daming W; Qian C; Xia F; He F; Yamasaki S; Nishida A; Harada T; Higa M; Tokunaga Y; Takagi A; Itokawa M; Kodama T; Kohara M
    J Epidemiol; 2022 Feb; 32(2):105-111. PubMed ID: 34776499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan.
    Tanaka A; Yamamoto S; Miyo K; Mizoue T; Maeda K; Sugiura W; Mitsuya H; Sugiyama H; Ohmagari N
    J Infect; 2021 Apr; 82(4):e1-e3. PubMed ID: 33524423
    [No Abstract]   [Full Text] [Related]  

  • 4. SARS-CoV-2 Infection among Medical Institution Faculty and Healthcare Workers in Tokyo, Japan.
    Nishimura T; Uwamino Y; Uno S; Kashimura S; Shiraki T; Kurafuji T; Morita M; Noguchi M; Azegami T; Yamada-Goto N; Murai-Takeda A; Yokoyama H; Kuwabara K; Kato S; Matsumoto M; Hirata A; Iida M; Harada S; Ishizaka T; Misawa K; Murata M; Saya H; Amagai M; Kitagawa Y; Takeuchi T; Mori M; Takebayashi T; Hasegawa N;
    Intern Med; 2021 Aug; 60(16):2569-2575. PubMed ID: 34148952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological study using IgM and IgG antibody titers against SARS-CoV-2 in The University of Tokyo, Japan (UT-CATS).
    Mitani A; Hamada K; Yoshikawa N; Morita Y; Horie T; Inoue Y; Saito M; Ishii T; Sunohara M; Takahashi R; Emoto N; Nishimoto N; Murano Y; Okazaki S; Tateishi S; Yao A; Shimura T; Kurano M; Yatomi Y; Yanagimoto S
    J Infect Chemother; 2021 Sep; 27(9):1342-1349. PubMed ID: 34158239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geographical Profiles of COVID-19 Outbreak in Tokyo: An Analysis of the Primary Care Clinic-Based Point-of-Care Antibody Testing.
    Takita M; Matsumura T; Yamamoto K; Yamashita E; Hosoda K; Hamaki T; Kusumi E
    J Prim Care Community Health; 2020; 11():2150132720942695. PubMed ID: 32674696
    [No Abstract]   [Full Text] [Related]  

  • 7. Cumulative and undiagnosed SARS-CoV-2 infection among the staff of a medical research centre in Tokyo after the emergence of variants.
    Mizoue T; Yamamoto S; Oshiro Y; Inamura N; Nemoto T; Horii K; Okudera K; Konishi M; Ozeki M; Sugiyama H; Aoyanagi N; Sugiura W; Ohmagari N
    Epidemiol Infect; 2023 Mar; 151():e48. PubMed ID: 36960731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India.
    Khan MS; Haq I; Qurieshi MA; Majid S; Bhat AA; Qazi TB; Chowdri IN; Sabah I; Kawoosa MF; Lone AA; Nabi S; Sumji IA; Obaid M; Kousar R
    J Hosp Med; 2021 May; 16(5):274-281. PubMed ID: 33929947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic.
    Pereckaitė L; Dambrauskienė A; Urbonienė D; Sadauskas S; Petrikonis K; Naudžiūnas A; Vitkauskienė A
    Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562085
    [No Abstract]   [Full Text] [Related]  

  • 10. Universal Polymerase Chain Reaction Screening for Severe Acute Respiratory Syndrome Coronavirus 2 in Asymptomatic Patients Before Hospital Admission in Tokyo, Japan.
    Uchida S; Uwamino Y; Uno S; Nagata M; Aoki W; Murata M; Kitagawa Y; Hasegawa N;
    J Clin Virol; 2021 Sep; 142():104915. PubMed ID: 34315009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan.
    Yazaki S; Yoshida T; Kojima Y; Yagishita S; Nakahama H; Okinaka K; Matsushita H; Shiotsuka M; Kobayashi O; Iwata S; Narita Y; Ohba A; Takahashi M; Iwasa S; Kobayashi K; Ohe Y; Yoshida T; Hamada A; Doi T; Yamamoto N
    JAMA Oncol; 2021 Aug; 7(8):1141-1148. PubMed ID: 34047762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nosocomial outbreak of coronavirus disease in two general wards during the initial wave of the pandemic in 2020, 
Tokyo, Japan.
    Sakamoto N; Ota M; Takeda T; Kosaka A; Washino T; Iwabuchi S; Beppu M; Nishiduka I; Matsui T; Suzuki M; Nakamura-Uchiyama F
    Western Pac Surveill Response J; 2022; 13(1):1-5. PubMed ID: 35494413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo.
    Fukuda H; Seyama K; Ito K; Ai T; Nojiri S; Hori S; Wakita M; Saito K; Shida Y; Nagura R; Hasegawa M; Kanemoto C; Tokuhara M; Okajima K; Yoshikawa Y; Katsuta N; Yamamoto T; Idei M; Horiuchi Y; Yamatani K; Misawa S; Naito T; Miida T; Sato H; Hattori N; Tabe Y; Takahashi K
    Sci Rep; 2021 Apr; 11(1):8380. PubMed ID: 33863960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients.
    Hiki M; Tabe Y; Ai T; Matsue Y; Harada N; Sugimoto K; Matsushita Y; Matsushita M; Wakita M; Misawa S; Idei M; Miida T; Tamura N; Takahashi K; Naito T
    PLoS One; 2021; 16(4):e0249449. PubMed ID: 33822809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Seroprevalence among Healthcare Workers in General Hospitals and Clinics in Japan.
    Yoshihara T; Ito K; Zaitsu M; Chung E; Aoyagi I; Kaji Y; Tsuru T; Yonemura T; Yamaguchi K; Nakayama S; Tanaka Y; Yurino N; Koyanagi H; Matsuki S; Urae R; Irie S
    Int J Environ Res Public Health; 2021 Apr; 18(7):. PubMed ID: 33916399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of SARS-CoV-2 specific IgG antibodies in District Srinagar, northern India - A cross-sectional study.
    Khan SMS; Qurieshi MA; Haq I; Majid S; Bhat AA; Nabi S; Ganai NA; Zahoor N; Nisar A; Chowdri IN; Qazi TB; Kousar R; Lone AA; Sabah I; Nabi S; Sumji IA; Kawoosa MF; Ayoub S
    PLoS One; 2020; 15(11):e0239303. PubMed ID: 33175878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymerase-chain reaction testing to prevent hospital-acquired severe acute respiratory syndrome coronavirus 2 infection in Shinjuku, an epicenter in Tokyo: The Tokyo Women's Medical University model.
    Arimura K; Tagaya E; Kikuchi K; Mitsuda T; Yasuda G; Azuma H; Konda N; Ikarashi Y; Chiba Y; Kusama K; Sakama R; Hagiwara S; Shimizu S; Shimamoto K; Nomura M; Yaguchi A; Niinami H; Kondo M; Tanabe K; Kawana M
    Respir Investig; 2021 May; 59(3):356-359. PubMed ID: 33579647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation.
    Jääskeläinen AJ; Kuivanen S; Kekäläinen E; Ahava MJ; Loginov R; Kallio-Kokko H; Vapalahti O; Jarva H; Kurkela S; Lappalainen M
    J Clin Virol; 2020 Aug; 129():104512. PubMed ID: 32563180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence and characteristics of Coronavirus Disease (COVID-19) in workers with non-specific disease symptoms.
    Javed W; Abidi SHB; Baqar JB
    BMC Infect Dis; 2022 May; 22(1):481. PubMed ID: 35596145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of SARS-CoV-2 antibodies among 925 staff members in an urban hospital accepting COVID-19 patients in Osaka prefecture, Japan: A cross-sectional study.
    Nishida T; Iwahashi H; Yamauchi K; Kinoshita N; Okauchi Y; Suzuki N; Inada M; Abe K
    Medicine (Baltimore); 2021 Jun; 100(25):e26433. PubMed ID: 34160433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.